State SC
Clinical Trials in South Carolina
Recruiting clinical trials with at least one study location in South Carolina. Data updated daily from ClinicalTrials.gov.
Top Conditions in South Carolina
Frequently Asked Questions — Clinical Trials in South Carolina
How many clinical trials are currently recruiting in South Carolina?
ClinicalMetric currently tracks 188 actively recruiting clinical trials with at least one location in South Carolina. The total number of registered studies—including active but not currently enrolling trials—is 188. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Carolina?
South Carolina hosts clinical trials across a broad range of medical conditions, including Asthma, Opioid Use Disorder, Head and Neck Squamous Cell Carcinoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Carolina serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Carolina?
To join a clinical trial in South Carolina, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Carolina maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in South Carolina
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT07278518 N/A
Recruiting
Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenor...
Condition
Opioid Use Disorder
Enrollment
20 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06451003 N/A
Recruiting
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylax...
Condition
Venous Thromboembolism
Enrollment
30 pts
Location
United States
Sponsor
Medical University of South Ca
NCT07142356 Phase 2
Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Condition
Uncontrolled Hypertension
Enrollment
280 pts
Location
United States
Sponsor
Retension Pharmaceuticals. Inc
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT05397639 Phase 3
Recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Condition
Agitation
Enrollment
375 pts
Location
United States, Croatia, Poland
Sponsor
Suven Life Sciences Limited
NCT07288138 Phase 2
Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicar...
Condition
Metabolic Dysfunction-associated Steatohepatitis
Enrollment
160 pts
Location
United States
Sponsor
Eccogene
NCT06812078 Phase 2
Recruiting
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Condition
Idiopathic Hypersomnia
Enrollment
96 pts
Location
United States, France, Hong Kong
Sponsor
Takeda
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05145491 N/A
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Condition
Epiretinal Membrane
Enrollment
400 pts
Location
United States, United Kingdom
Sponsor
Jaeb Center for Health Researc
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
NCT04174157 N/A
Recruiting
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Condition
Spinal Muscular Atrophy (SMA)
Enrollment
700 pts
Location
United States, Greece, Ireland
Sponsor
Novartis Pharmaceuticals
NCT05603728 N/A
Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Condition
Osteo Arthritis Shoulders
Enrollment
20,000 pts
Location
United States, Canada, France
Sponsor
Exactech
NCT07249801 N/A
Recruiting
Closed-loop rTMS-EEG During Visuomotor Integration.
Condition
Visuomotor Skills
Enrollment
20 pts
Location
United States
Sponsor
Medical University of South Ca
NCT05366881 N/A
Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and ...
Condition
Brain Cancer
Enrollment
7,000 pts
Location
United States
Sponsor
Adela, Inc
NCT05904028 Phase 3
Recruiting
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
600 pts
Location
United States, Canada
Sponsor
Jaeb Center for Health Researc
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT07456865 N/A
Recruiting
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial De...
Condition
Urge Urinary Incontinence
Enrollment
256 pts
Location
United States
Sponsor
MedtronicNeuro
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT05959434 Phase 2
Recruiting
Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol U...
Condition
Posttraumatic Stress Disorder
Enrollment
200 pts
Location
United States
Sponsor
Texas A&M University
NCT05486234 N/A
Recruiting
CARS: Cannabis and Alcohol Reduction Study
Condition
Cannabis Use
Enrollment
52 pts
Location
United States
Sponsor
Medical University of South Ca
NCT06526195 N/A
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in ...
Condition
Heart Failure
Enrollment
850 pts
Location
United States, Austria, Czechia
Sponsor
Abbott Medical Devices
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology